United States Infusion Systems Market Outlook to 2023

Published : Aug-2017

No. of Pages : 113

order by fax Inquire before Buying request discount

"Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Infusion Systems Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Infusion Systems Market, United States 9
3.1 Infusion Systems Market, United States, Revenue ($m), 2009-2016 9
3.2 Infusion Systems Market, United States, Revenue ($m), 2016-2023 11
3.2.1 Ambulatory Infusion Pumps Market, United States, Revenue ($m), by Segment, 2009-2016 13
3.2.2 Syringe Pumps Market, United States, Revenue ($m), by Segment, 2009-2016 15
3.2.3 Ambulatory Infusion Pumps Market, United States, Revenue ($m), by Segment, 2016-2023 17
3.2.4 Syringe Pumps Market, United States, Revenue ($m), by Segment, 2016-2023 19
3.3 Infusion Systems Market, United States, Volume (Units), 2009-2016 21
3.4 Infusion Systems Market, United States, Volume (Units), 2016-2023 23
3.4.1 Ambulatory Infusion Pumps Market, United States, Volume (Units), by Segment, 2009-2016 25
3.4.2 Syringe Pumps Market, United States, Volume (Units), by Segment, 2009-2016 27
3.4.3 Ambulatory Infusion Pumps Market, United States, Volume (Units), by Segment, 2016-2023 29
3.4.4 Syringe Pumps Market, United States, Volume (Units), by Segment, 2016-2023 31
3.5 Infusion Systems Market, United States, Average Price ($), 2009-2023 33
3.6 Infusion Systems Market, United States, Distribution Share by Revenue ($m), 2015-2016 35
3.7 Infusion Systems Market, United States, Company Share by Revenue ($m), 2016 36
4 Overview of Key Companies in United States, Infusion Systems Market 38
4.1 Hospira Inc 38
4.1.1 Company Overview 38
4.2 Becton Dickinson and Co 38
4.2.1 Company Overview 38
4.3 Baxter International Inc 38
4.3.1 Company Overview 38
4.4 Medtronic Plc 39
4.4.1 Company Overview 39
4.5 Fresenius Kabi AG 39
4.5.1 Company Overview 39
4.6 Smiths Medical 39
4.6.1 Company Overview 39
4.7 B. Braun Melsungen AG 39
4.7.1 Company Overview 39
4.8 Nipro Corp 40
4.8.1 Company Overview 40
5 Infusion Systems Market Pipeline Products 41
6 Financial Deals Landscape 42
6.1 Acquisition 42
6.1.1 Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 42
6.2 Debt Offerings 45
6.2.1 PAVmed Raises USD5 Million in Private Placement of Notes and Warrants 45
6.3 Equity Offerings 46
6.3.1 AngioDynamics Prices Public Offering of Shares for USD38 Million 46
6.3.2 PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants 48
6.3.3 PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units 49
6.3.4 PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units 50
6.3.5 AngioDynamics Prices Public Offering of Shares for USD32 Million 51
6.3.6 PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 53
6.3.7 ConvaTec Raises USD1.8 Billion in IPO 54
6.4 Partnerships 56
6.4.1 Iatric Systems Enters into Agreement with Hospira 56
6.5 Private Equity 57
6.5.1 410 Medical Raises USD3.3 Million in Series A Financing 57
6.6 Venture Financing 58
6.6.1 410 Medical Raises Additional USD2.1 Million in Series A Financing 58
6.6.2 Ivenix Raises USD50 Million in First Tranche of Equity Financing 59
6.6.3 Ivenix Raises USD10 Million in Venture Financing 60
6.6.4 Surefire Medical Raises USD12.8 Million in First Round of Series D Financing 61
7 Recent Developments 62
7.1 Corporate Communications 62
7.1.1 Apr 03, 2017: RMS Strengthens Global Sales Team 62
7.1.2 Mar 30, 2017: IRADIMED Names John McCreery Chief Operating Officer 62
7.1.3 Mar 21, 2017: PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer 62
7.1.4 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 63
7.1.5 Jan 20, 2017: RMS Medical Announces Hiring of Eric Bauer as Chief Operating Officer 64
7.1.6 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 64
7.1.7 Sep 29, 2016: Medipacs Appoints Michael J. Kamdar as Executive Chairman 65
7.1.8 Sep 26, 2016: Jon Giacomin of Cardinal Health Elected Chairman of HDA Board of Directors 65
7.1.9 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 66
7.2 Financial Announcements 66
7.2.1 May 22, 2017: PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update 66
7.2.2 May 08, 2017: Alimera Sciences Reports First Quarter 2017 Financial Results 67
7.2.3 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017 68
7.2.4 Apr 28, 2017: Iradimed Announces First Quarter 2017 Financial Results 69
7.2.5 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 69
7.2.6 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 71
7.2.7 Apr 23, 2017: Bard Announces First Quarter Results 72
7.2.8 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years 73
7.2.9 Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 73
7.2.10 Mar 01, 2017: Alimera Sciences Reports Record Fourth Quarter and Full Year 2016 Financial Results 74
7.2.11 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 76
7.2.12 Feb 06, 2017: IRADIMED Announces Fourth Quarter 2016 Financial Results 77
7.2.13 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 78
7.2.14 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 80
7.2.15 Jan 26, 2017: Bard Announces Fourth Quarter Results 81
7.2.16 Jan 18, 2017: IRADIMED Announces 2017 Annual and First Quarter Financial Guidance 82
7.2.17 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 82
7.2.18 Dec 27, 2016: RMS Medical Products Posts Third Quarter 2017 Results 83
7.2.19 Nov 02, 2016: Alimera Sciences Announces Third Quarter 2016 Financial Results and Provides Business Update 84
7.2.20 Oct 31, 2016: Cardinal Health Reports First-quarter Results for Fiscal Year 2017 86
7.2.21 Oct 28, 2016: IRADIMED Announces Third Quarter 2016 Financial Results 87
7.2.22 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 87
7.2.23 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 88
7.2.24 Oct 25, 2016: Bard Announces Third Quarter Results 90
7.2.25 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 90
7.2.26 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 91
7.2.27 Oct 04, 2016: IRADIMED Revises Financial Guidance for the Third Quarter and Full Year 2016 92
7.2.28 Aug 16, 2016: PAVmed Announces Second Quarter 2016 Financial Results and Provides Business Update 93
7.2.29 Aug 03, 2016: Alimera Sciences Announces Second Quarter 2016 Financial Results and Provides Business Update 93
7.2.30 Aug 02, 2016: Cardinal Health Reports Q4 And Fiscal 2016 Results, Provides Fiscal 2017 Outlook 95
7.2.31 Jul 29, 2016: IRADIMED Announces Second Quarter 2016 Financial Results 96
7.2.32 Jul 26, 2016: Alimera Sciences Pre-Announces Record Second Quarter 2016 Revenue 97
7.2.33 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 97
7.2.34 Jul 26, 2016: Bard Announces Second Quarter Results 98
7.2.35 Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016 99
7.2.36 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 100
7.2.37 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 101
7.3 Government and Public Interest 103
7.3.1 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 103
7.4 Legal And Regulatory 104
7.4.1 May 22, 2017: Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome-Data Presented at Antiepileptic Drug Trials XIV 2017 Conference 104
7.4.2 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia 105
7.4.3 Dec 23, 2016: Cardinal Health Announces Civil Settlement with DOJ 106
7.5 Other Significant Developments 106
7.5.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 106
7.5.2 Nov 30, 2016: Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software 107
7.5.3 Oct 11, 2016: Fresenius Kabi Joins Chicago Health Innovation Incubator MATTER as Newest Strategic Partner 107
7.6 Product News 108
7.6.1 Mar 20, 2017: Surefire Receives Regulatory Approval for Infusion Systems and Guiding Catheters in Mexico 108
8 Appendix 109
8.1 Research Methodology 110
8.1.1 Coverage 110
8.1.2 Secondary Research 110
8.1.3 Primary Research 111
8.1.4 Company Share Analysis 111
8.1.5 Distribution Share Analysis 111
8.1.6 Benchmarking 112
8.2 GlobalData Consulting 112
8.3 Contact Us 113
8.4 Disclaimer 113

1.1 List of Tables
Table 1: Infusion Systems Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 10
Table 2: Infusion Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 12
Table 3: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 14
Table 4: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 16
Table 5: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Table 6: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 20
Table 7: Infusion Systems Market, United States, Volume (Units), Historic, 2009-2016 22
Table 8: Infusion Systems Market, United States, Volume (Units), Forecast, 2016-2023 24
Table 9: Ambulatory Infusion Pumps Market, United States, Volume (Units), Historic, 2009-2016 26
Table 10: Syringe Pumps Market, United States, Volume (Units), Historic, 2009-2016 28
Table 11: Ambulatory Infusion Pumps Market, United States, Volume (Units), Forecast, 2016-2023 30
Table 12: Syringe Pumps Market, United States, Volume (Units), Forecast, 2016-2023 32
Table 13: Infusion Systems Market, United States, Average Price ($), Historic, 2009-2016 33
Table 14: Infusion Systems Market, United States, Average Price ($), Forecast, 2016-2023 34
Table 15: Infusion Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 35
Table 16: Infusion Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2016 37
Table 17: Infusion Systems Market Pipeline Products 41
Table 18: Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 42
Table 19: PAVmed Raises USD5 Million in Private Placement of Notes and Warrants 45
Table 20: AngioDynamics Prices Public Offering of Shares for USD38 Million 46
Table 21: PAVmed to Raise USD10.4 Million in Private Placement of Shares upon Exercise of Warrants 48
Table 22: PAVmed Raises Additional Funds in Second and Final Tranche of Private Placement of Units 49
Table 23: PAVmed Raises USD1.5 Million in First Tranche of Private Placement of Units 50
Table 24: AngioDynamics Prices Public Offering of Shares for USD32 Million 51
Table 25: PAVmed to Raise USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 53
Table 26: ConvaTec Raises USD1.8 Billion in IPO 54
Table 27: Iatric Systems Enters into Agreement with Hospira 56
Table 28: 410 Medical Raises USD3.3 Million in Series A Financing 57
Table 29: 410 Medical Raises Additional USD2.1 Million in Series A Financing 58
Table 30: Ivenix Raises USD50 Million in First Tranche of Equity Financing 59
Table 31: Ivenix Raises USD10 Million in Venture Financing 60
Table 32: Surefire Medical Raises USD12.8 Million in First Round of Series D Financing 61

1.2 List of Figures
Figure 1: Infusion Systems Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 9
Figure 2: Infusion Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 11
Figure 3: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 13
Figure 4: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 15
Figure 5: Ambulatory Infusion Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 17
Figure 6: Syringe Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Figure 7: Infusion Systems Market, United States, Volume (Units), Historic, 2009-2016 21
Figure 8: Infusion Systems Market, United States, Volume (Units), Forecast, 2016-2023 23
Figure 9: Ambulatory Infusion Pumps Market, United States, Volume (Units), Historic, 2009-2016 25
Figure 10: Syringe Pumps Market, United States, Volume (Units), Historic, 2009-2016 27
Figure 11: Ambulatory Infusion Pumps Market, United States, Volume (Units), Forecast, 2016-2023 29
Figure 12: Syringe Pumps Market, United States, Volume (Units), Forecast, 2016-2023 31
Figure 13: Infusion Systems Market, United States, Company Share (%) 2016 36"

Filed in: Medical Device, Orthopedic Devices

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

United States Infusion Systems Market Outlook to 2023

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027